The COVID-19 pandemic might feel like déjà vu for Kent Brantly, M.D. (’03), who contracted the deadly Ebola virus in 2014 while serving as a medical missionary in Liberia. He became the first Ebola patient to receive the experimental drug ZMapp and the first to be flown back to the U.S. for treatment. Six years … Continued